Odonate Therapeutics Revenue 2016-2019 | ODT

Odonate Therapeutics revenue from 2016 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Odonate Therapeutics Annual Revenue
(Millions of US $)
2018 $
2017 $
2016 $
2015 $
Odonate Therapeutics Quarterly Revenue
(Millions of US $)
Q3 2019
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q4 2015
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.104B $0.000B
Odonate Therapeutics, LLC is a pharmaceutical company. It engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer. Odonate Therapeutics, LLC is based in SAN DIEGO, United States.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $64.088B 10.13
Zoetis (ZTS) United States $57.113B 34.16
Astellas Pharma (ALPMY) Japan $32.412B 16.19
Eisai (ESALY) Japan $20.839B 40.18
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.573B 20.41
Merck (MKGAF) Germany $14.921B 20.36
Neurocrine Biosciences (NBIX) United States $10.753B 507.65
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.341B 0.00
Ionis Pharmaceuticals (IONS) United States $8.987B 18.20
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.507B 10.87
Sage Therapeutics (SAGE) United States $7.887B 0.00
Catalent (CTLT) United States $7.525B 30.61
Arrowhead Pharmaceuticals (ARWR) United States $6.061B 91.78
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.986B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.992B 17.94
United Therapeutics (UTHR) United States $4.029B 0.00
FibroGen (FGEN) United States $3.839B 112.82
Taro Pharmaceutical Industries (TARO) Israel $3.705B 13.54
Nektar Therapeutics (NKTR) United States $3.427B 0.00
Evotec AG (EVTCY) Germany $3.182B 52.07
PTC Therapeutics (PTCT) United States $2.934B 0.00
Heron Therapeutics (HRTX) United States $2.357B 0.00
Xencor (XNCR) United States $2.166B 65.83
Portola Pharmaceuticals (PTLA) United States $2.154B 0.00
Zogenix (ZGNX) United States $2.101B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.927B 57.00
Tilray (TLRY) Canada $1.911B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.861B 59.35
ChemoCentryx (CCXI) United States $1.690B 0.00
USANA Health Sciences (USNA) United States $1.594B 17.01
Corcept Therapeutics (CORT) United States $1.497B 18.19
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.240B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.224B 27.95
Endo (ENDP) Ireland $1.153B 2.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.149B 7.84
ArQule (ARQL) United States $1.104B 0.00
Karyopharm Therapeutics (KPTI) United States $1.072B 0.00
Radius Health (RDUS) United States $1.005B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.991B 0.00
Aerie Pharmaceuticals (AERI) United States $0.874B 0.00
Collegium Pharmaceutical (COLL) United States $0.746B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.715B 0.00
Flexion Therapeutics (FLXN) United States $0.685B 0.00
TherapeuticsMD (TXMD) United States $0.656B 0.00
Akebia Therapeutics (AKBA) United States $0.633B 0.00
Translate Bio (TBIO) United States $0.589B 0.00
ImmunoGen (IMGN) United States $0.533B 0.00
Concordia (CXRXF) Canada $0.482B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.478B 58.00
Crinetics Pharmaceuticals (CRNX) United States $0.469B 0.00
Organogenesis Holdings (ORGO) United States $0.467B 0.00
Ardelyx (ARDX) United States $0.455B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.443B 0.00
Dermira (DERM) United States $0.438B 0.00
Molecular Templates (MTEM) United States $0.431B 0.00
DURECT (DRRX) United States $0.421B 0.00
Harpoon Therapeutics (HARP) United States $0.419B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.410B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.403B 17.36
OptiNose (OPTN) United States $0.390B 0.00
Recro Pharma (REPH) United States $0.389B 0.00
Siga Technologies (SIGA) United States $0.387B 8.83
Indivior (INVVY) United States $0.377B 1.36
Rigel Pharmaceuticals (RIGL) United States $0.365B 0.00
Lannett Co Inc (LCI) United States $0.353B 4.10
Innate Pharma SA (IPHYF) France $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.299B 0.00
KalVista Pharmaceuticals (KALV) United States $0.271B 0.00
Rafael Holdings (RFL) United States $0.263B 0.00
GlycoMimetics (GLYC) United States $0.254B 0.00
Calithera Biosciences (CALA) United States $0.247B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.230B 0.00
Xeris Pharmaceuticals (XERS) United States $0.229B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 2.90
Matinas Biopharma Holdings (MTNB) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.191B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.77
Concert Pharmaceuticals (CNCE) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.148B 0.00
Redhill Biopharma (RDHL) Israel $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
MEI Pharma (MEIP) United States $0.145B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.122B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.115B 0.00
CV Sciences (CVSI) United States $0.112B 0.00
CannTrust Holdings (CTST) Canada $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.107B 0.00
Majesco Entertainment (PTE) United States $0.086B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 23.80
Neos Therapeutics (NEOS) United States $0.079B 0.00
Otonomy (OTIC) United States $0.078B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.074B 0.00
Capnia (SLNO) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.069B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.064B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Novan (NOVN) United States $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Natural Alternatives (NAII) United States $0.056B 13.89
Medicure (MCUJF) Canada $0.055B 0.00
Mast Therapeutics (SVRA) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
AgeX Therapeutics (AGE) United States $0.051B 0.00
IntelGenx Technologies (IGXT) Canada $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
IsoRay (ISR) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
India Globalization Capital (IGC) United States $0.030B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Can-Fite Biopharma (CANF) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00